Naphthalene

Naphthalene

SCHEMBL4609645

NC(N)=O.c1ccc2ccccc2c1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.57
ALOX12 P18054 1/20 0.57
HSD17B10 Q99714 3/20 0.50
TSHR P16473 3/20 0.50
MAPT P10636 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP3A4 P08684 2/20 0.50
POLB P06746 1/20 0.50
PARP1 P09874 1/20 0.50
CYP2C19 P33261 1/20 0.50
RECQL P46063 1/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
KDM4E B2RXH2 4/20 0.46
GAA P10253 2/20 0.46
ALDH1A1 P00352 5/20 0.44
F2 P00734 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL29011577 0.90 CYP2C19 (0.55) CYP2A6ALOX12HSD17B10TSHRMAPT
Naphthalene SCHEMBL3359766 0.90 CYP2C19 (0.55) CYP2A6ALOX12HSD17B10TSHRMAPT
Naphthalene SCHEMBL717001 0.87 BLM (0.50) CYP2A6ALOX12HSD17B10TSHRMAPT
Naphthalene SCHEMBL9732717 0.86 ALOX12 (0.42) CYP2A6ALOX12HSD17B10TSHRMAPT
Naphthalene SCHEMBL29132366 0.84 SIGMAR1 (0.41) CYP2A6ALOX12HSD17B10TSHRMAPT
Naphthalene SCHEMBL587722 0.82 GAA (0.50) CYP2A6ALOX12HSD17B10TSHRMAPT
Terephthalamide SCHEMBL7564599 0.82 PARP1 (0.70) HSD17B10TSHRMAPTTDP1CYP3A4
Naphthalene SCHEMBL28793702 0.82 CYP2A6 (0.44) CYP2A6ALOX12HSD17B10TSHRMAPT
Naphthalene SCHEMBL5180063 0.82 ALOX12 (0.44) CYP2A6ALOX12HSD17B10TSHRMAPT
Naphthalene SCHEMBL3369808 0.82 GAA (0.50) CYP2A6ALOX12HSD17B10TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113507936-A Encapsulated glycolipid antigens for the treatment of neoplastic disease 安吉尼科分子传输公司 2021-10-15 CN claimed
EP-0515523-A4 USE OF SURAMIN TO TREAT RHEUMATOLOGIC DISEASES US COMMERCE (US) 1993-02-10 EP claimed
EP-0515523-A1 USE OF SURAMIN TO TREAT RHEUMATOLOGIC DISEASES THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) 1992-12-02 EP claimed
WO-1991012009-A1 USE OF SURAMIN TO TREAT RHEUMATOLOGIC DISEASES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) 1991-08-22 WO claimed
WO-2024124411-A1 USE OF NAPHTHYLUREA COMPOUNDS IN PREPARATION OF DRUGS FOR TREATING PTERYGIUM 苏州锐明新药研发有限公司 2024-06-20 WO disclosed
CN-116731551-B Environment-friendly paint remover for aviation use and preparation method and application thereof 广东润和新材料科技有限公司 2024-06-04 CN disclosed
CN-116731551-A Environment-friendly paint remover for aviation use and preparation method and application thereof 广东润和新材料科技有限公司 2023-09-12 CN disclosed
CN-115487183-A Use of naphthoyl urea compound in preparing medicine for treating pterygium 苏州锐明新药研发有限公司 2022-12-20 CN disclosed
CN-113507936-A Encapsulated glycolipid antigens for the treatment of neoplastic disease 安吉尼科分子传输公司 2021-10-15 CN disclosed
CN-110462867-A Organic electroluminescent device KONICA MINOLTA INC 2019-11-15 CN disclosed
CN-106133886-B Semiconductor element and composition for forming insulating layer 富士胶片株式会社 2019-07-30 CN disclosed
CN-109983597-A Organic electroluminescent device 柯尼卡美能达株式会社 2019-07-05 CN disclosed
WO-1998052554-A1 SPIROCYCLOPROPYL FLUORENES AS MELATONERGIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-11-26 WO disclosed
EP-0718286-B1 3-Alkoxybenzylpiperidine derivatives as melatonergic agents BRISTOL MYERS SQUIBB CO (US) 1998-07-29 EP disclosed
WO-1998025606-A1 BENZODIOXOLE, BENZOFURAN, DIHYDROBENZOFURAN, AND BENZODIOXANE MELATONERGIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-06-18 WO disclosed
US-5661185-A AN ALKOXYPHENYL-ALKYLUREA COMPOUND TREATING SLEEP DISORDER BRISTOL-MYERS SQUIBB CO. (US) 1997-08-26 US disclosed
US-5541228-A Melatonergic agents BRISTOL-MYERS SQUIBB CO. (US) 1996-07-30 US disclosed
EP-0718286-A1 3-Alkoxybenzylpiperidine derivatives as melatonergic agents BRISTOL-MYERS SQUIBB COMPANY (US) 1996-06-26 EP disclosed
US-5530012-A FOR SLEEP DISORDERS, DEPRESSION, GLAUCOMA, CANCER BRISTOL-MYERS SQUIBB CO. (US) 1996-06-25 US disclosed
EP-0706994-A1 Melatonergic agents BRISTOL-MYERS SQUIBB COMPANY (US) 1996-04-17 EP disclosed